Stockscreener 앱 받기
10.00
2.25%
-0.23
시장 영업 전:
9.70
-0.30
-3.00%
전일 마감가:
$10.23
열려 있는:
$10.12
하루 거래량:
233.67K
Relative Volume:
0.51
시가총액:
$622.97M
수익:
$198.53M
순이익/손실:
$-63.68M
주가수익비율:
-9.7828
EPS:
-1.0222
순현금흐름:
$-41.50M
1주 성능:
-4.85%
1개월 성능:
+36.99%
6개월 성능:
+72.71%
1년 성능:
-35.11%
1일 변동 폭
$9.82
$10.40
1주일 범위
$9.82
$10.79
52주 변동 폭
$3.92
$15.98
트리스 메디컬 컨셉트 Stock (TMCI) Company Profile
명칭
Treace Medical Concepts Inc
전화
(904) 373-5940
주소
100 PALMETTO PARK PLACE, PONTE VEDRA
TMCI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
10.00 | 622.97M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
131.44 | 227.98B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.98 | 156.20B | 16.75B | 1.85B | 1.89B | 1.25 |
|
SYK
Stryker Corp
|
390.48 | 148.86B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
91.20 | 116.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.91 | 41.82B | 6.60B | 4.16B | 490.10M | 6.93 |
트리스 메디컬 컨셉트 Stock (TMCI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-04 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-12-31 | 개시 | Lake Street | Buy |
| 2024-12-17 | 재개 | JP Morgan | Neutral |
| 2024-05-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-08 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-05-08 | 다운그레이드 | Truist | Buy → Hold |
| 2023-09-29 | 개시 | UBS | Buy |
| 2023-05-01 | 개시 | Truist | Buy |
| 2023-04-11 | 개시 | Stephens | Equal-Weight |
| 2022-05-12 | 개시 | BTIG Research | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | 개시 | JP Morgan | Overweight |
| 2021-05-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-05-18 | 개시 | SVB Leerink | Outperform |
| 2021-05-18 | 개시 | Stifel | Buy |
모두보기
트리스 메디컬 컨셉트 주식(TMCI)의 최신 뉴스
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $9.99 Consensus Price Target from Analysts - Defense World
Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) PT at $9.99 - MarketBeat
Insider Stock Buying Reaches US$7.31m On Treace Medical Concepts - Yahoo Finance
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Position Increased by SG Americas Securities LLC - Defense World
Treace Medical Concepts (NASDAQ:TMCI) Shares Gap UpWhat's Next? - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Upgraded by BTIG Research to Buy Rating - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Upgraded at BTIG Research - Armenian Reporter
Treace to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025 - The Manila Times
Treace Medical Earnings: Bunion Surgery Leader Reports Q4 Results & Growth Outlook - StockTitan
BTIG raises Treace Medical stock to Buy, sets $16 target - MSN
Why Treace Medical Concepts (TMCI) Is Rallying Today - Insider Monkey
BTIG Upgrades Treace Medical Concepts to Buy From Neutral, Price Target is $16 -February 04, 2025 at 07:33 am EST - Marketscreener.com
Morgan Stanley Reduces Stake in Treace Medical Concepts Inc - GuruFocus.com
Treace Medical Concepts, Inc. Announces First Surgical Cases Utilizing the Speedakin Anatomic Compression Implant - Marketscreener.com
Revolutionary Bunion Surgery Implant Eliminates Metal Allergy RiskTreace Medical's Latest Innovation - StockTitan
Treace Medical Concepts (NASDAQ:TMCI) Shares Up 5.1%Time to Buy? - MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Purchased by Barclays PLC - Defense World
Barclays PLC Increases Stock Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Stock Rockets 26% But Many Are Still Ignoring The Company - Simply Wall St
Treace Medical Concepts reports Q4 preliminary revenue of $68.4M$68.8M - MSN
Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) Price Target at $8.98 - Defense World
JPMorgan Chase & Co. Grows Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
JPMorgan Chase & Co. Has $7.32 Million Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
TMCI Stock May Gain From the Limited Release of the Percuplasty System - MSN
Treace Medical Concepts (NASDAQ:TMCI) Trading 10.3% HigherTime to Buy? - MarketBeat
Treace Medical Concepts Reports Strong 2024 Revenue Growth - TipRanks
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2024 Revenue - The Manila Times
Treace Medical Q4 Revenue Hits $68.8M as Bunion Surgery Network Expands to 3,135 Surgeons - StockTitan
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
The Law Offices of Frank R. Cruz Continues Its Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors - Business Wire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Position Reduced by Geode Capital Management LLC - Defense World
Barclays PLC Raises Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Insiders Of Treace Medical Concepts Are Up 58% On Their US$7.31m Purchase - Simply Wall St
Franklin Resources Inc. Acquires Shares of 36,487 Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Treace Medical CEO to Present at J.P. Morgan Healthcare Conference on Bunion Surgery Innovation - StockTitan
Treace Medical Concepts (NASDAQ:TMCI) Coverage Initiated by Analysts at Lake Street Capital - Defense World
Lake Street Initiates Coverage of Treace Medical Concepts (TMCI) with Buy Recommendation - MSN
This Vertex Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Tuesday - Benzinga
Treace Medical Concepts (NASDAQ:TMCI) Now Covered by Analysts at Lake Street Capital - MarketBeat
Lake Street initiates Buy rating on Treace Medical stock, highlighting 15% growth potential - Investing.com
Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure - The Manila Times
Treace Medical Launches Groundbreaking Minimally Invasive Bunion Surgery System Targeting 450,000 Annual Procedures - StockTitan
Who Holds the Power? Discover the Forces Behind Treace Medical Concepts! - Jomfruland.net
With 54% institutional ownership, Treace Medical Concepts, Inc. (NASDAQ:TMCI) is a favorite amongst the big guns - Yahoo Finance
State Street Corp Raises Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
10,003 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Acquired by HighTower Advisors LLC - Defense World
Stifel Financial Corp Has $776,000 Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $7.88 Average PT from Brokerages - Defense World
Treace Medical Concepts (NASDAQ:TMCI) Stock Price Expected to Rise, Truist Financial Analyst Says - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
트리스 메디컬 컨셉트 (TMCI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.38%
1.34%
자본화:
|
볼륨(24시간):